Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).

Background: A combination measles, mumps, rubella, and varicella vaccine (ProQuad, Merck & Co., Inc, West Point, PA) was evaluated in five clinical trials. Use of ProQuad would result in fewer injections for children and would facilitate universal immunization against all four diseases.